PGHH Declares ₹195 Interim Dividend, Including ₹25 Special Dividend
Procter & Gamble Hygiene and Health Care Limited declared an interim dividend of ₹195 per equity share for FY 2025-26, which includes a special dividend of ₹25. The record date for this dividend is February 5, 2026. The company has outlined TDS procedures for resident and non-resident shareholders.
A dividend declaration directly impacts shareholders by providing them with income. The amount declared is significant, but it is a routine event for established companies and does not fundamentally alter the company's business operations or market position.
The declaration of an interim dividend, especially one including a special dividend, is a positive signal for shareholders, indicating profitability and a commitment to returning value.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced its Board of Directors has declared an interim dividend of ₹195 per equity share for the Financial Year 2025-26. This includes a one-time special dividend of ₹25 per equity share. The dividend, with a face value of ₹10 each, will be paid to shareholders whose names appear on the company's register or in the depositories' records as beneficial owners by the close of business hours on February 5, 2026, which is the record date.
The company has also provided detailed information regarding the deduction of tax at source (TDS) on dividend income, in accordance with the Income Tax Act, 1961, as amended by the Indian Finance Act, 2020. Shareholders are requested to update their tax residential status, PAN, and other details with their respective depositories or the company's registrar and share transfer agent, M/s. MUFG Intime India Private Limited, to determine the applicable TDS rate.
For resident shareholders, the TDS rate is 10% if PAN is available, and 20% if PAN is not available or invalid. Shareholders providing valid Form 15G or 15H may be exempted from TDS, subject to eligibility conditions. For non-resident shareholders, the TDS rate is 20% plus applicable surcharge and cess, or the DTAA rate, whichever is lower, provided necessary documentation such as PAN, Tax Residency Certificate, and Form 10F is submitted.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.